Plain-English translation of NCT05406999 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether giving patients a combination of hormone-blocking medications—including abiraterone, , , or —before prostate surgery works better than giving hormone therapy alone. All patients will receive hormone therapy for about 6 months, and some groups will also receive one of these additional medications during that time. After the medication phase, everyone will have robot-assisted surgery to remove the prostate.
Advanced prostate cancer that has spread to nearby tissues or lymph nodes is serious and hard to treat. Doctors want to know if giving stronger medication combinations before surgery can shrink tumors more effectively and improve long-term outcomes for patients with this aggressive form of cancer.
You likely qualify if…
You likely don't qualify if…
You will take daily medication by mouth for 6 months (about 24 weeks). Depending on which group you are assigned to, you may receive hormone therapy alone or hormone therapy plus one of the additional medications being tested. Throughout this period, you will have regular clinic visits to check your health and monitor how you are responding. After the 6 months of medication, you will undergo robot-assisted surgery to remove your prostate gland, which will happen within 2 weeks of finishing treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China